Bisphosphonate determination using 1H-NMR spectroscopy for biomedical applications

Journal of Tissue Engineering and Regenerative Medicine

Volumn 3, Issue 2, 2009, Pages 92-96

  Chou, J ^a   Shimmon, R ^a   Ben Nissan, B ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Biomedical applications; Bisphosphonate; Nuclear magnetic resonance (NMR); Osteoporosis; Pharmaceutical

Indexed keywords

BONE; DISEASES; MAGNETISM; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ACTIVE DRUGS; BIOMEDICAL APPLICATIONS; BISPHOSPHONATES; BONE REGENERATION; INTERNAL STANDARDS; NUCLEAR MAGNETIC RESONANCE; PHARMACEUTICAL DRUGS; QUANTITATIVE NUCLEAR MAGNETIC RESONANCES; REFERENCE STANDARD; SOLVENT RESIDUES;

MEDICAL APPLICATIONS;

BENZYLAMINE; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ANALYTIC METHOD; ARTICLE; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; MEASUREMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STANDARD;

DIPHOSPHONATES; MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE STANDARDS;

EID: 66949163015     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.142     Document Type: Article

References (7)

1. Avdovich H, Lebelle MJ, Savard C, et al. 1991; Nuclear magnetic resonance identification and estimation of solvent residues in cocaine. Forens Sci Int 49: 225-235.
2. Diehl BWK, Malz F, Holzgrabe U. 2007; Quantitative NMR spectroscopy in the quality evaluation of active pharmaceutical indredients and excipients. Spectrosc Eur 19(5): 15-19.
3. Fleisch H. 1993; Bisphosphonates in osteoporosis: an introduction. Osteoporosis Int Suppl 3: S3-5.
4. Maniara G, Rajamoorthi K, Rajan S, et al. 1998; Method performance and validation for quantitative analysis by 1H and 31P NMR spectroscopy. Anal Chem 70(23): 4921-4928.
5. McLeod K, Anderson GI, Dutta NK, et al. 2006; Adsorption of bisphosphonate onto hydroxyapatite using a novel co-precipitation technique for bone growth enhancement. J Biomed Mater Res A 79A: 271-281.
6. Palazzo B, Iafisco M, Laforgia M, et al. 2007; Biomimetic hydroxyapatite - drug nanocrystals as potential bone substitutes with antitumor drug deliviery properties. Adv Funct Mater 17: 2180-2188.
7. Seshima H, Yoshinari M, Takemoto S, et al. 2006; Control of bisphosphonate release using hydroxyapatite granules. J Biomed Mater Res B 78B: 215-221.